Advertisement
Review Article| Volume 26, ISSUE 1, P21-40, January 2010

Acute Respiratory Failure in the Patient with Cancer: Diagnostic and Management Strategies

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hauser M.J.
        • Tabak J.
        • Baier H.
        Survival of patients with cancer in a medical critical care unit.
        Arch Intern Med. 1982; 142: 527-529
        • Staudinger T.
        • Stoiser B.
        • Mullner M.
        • et al.
        Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit.
        Crit Care Med. 2000; 28: 1322-1328
        • Azoulay E.
        • Thiery G.
        • Chevret S.
        • et al.
        The prognosis of acute respiratory failure in critically ill cancer patients.
        Medicine (Baltimore). 2004; 83: 360-370
        • Soares M.
        • Salluh J.I.
        • Spector N.
        • et al.
        Characteristics and outcomes of cancer patients requiring mechanical ventilatory support for >24 hrs.
        Crit Care Med. 2005; 33: 520-526
        • Peters S.G.
        • Meadows 3rd, J.A.
        • Gracey D.R.
        Outcome of respiratory failure in hematologic malignancy.
        Chest. 1988; 94: 99-102
        • Reichner C.A.
        • Thompson J.A.
        • O'Brien S.
        • et al.
        Outcome and code status of lung cancer patients admitted to the medical ICU.
        Chest. 2006; 130: 719-723
        • Benoit D.D.
        • Vandewoude K.H.
        • Decruyenaere J.M.
        • et al.
        Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication.
        Crit Care Med. 2003; 31: 104-112
        • Snow R.M.
        • Miller W.C.
        • Rice D.L.
        • et al.
        Respiratory failure in cancer patients.
        JAMA. 1979; 241: 2039-2042
        • Darmon M.
        • Thiery G.
        • Ciroldi M.
        • et al.
        Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy.
        Crit Care Med. 2005; 33: 2488-2493
        • Ewer M.
        • Ali M.K.
        • Atta M.S.
        • et al.
        Outcome of lung cancer patients requiring mechanical ventilation for pulmonary failure.
        JAMA. 1986; 256: 3364-3366
        • Lloyd-Thomas A.R.
        • Wright I.
        • Lister T.A.
        • et al.
        Prognosis of patients receiving intensive care for life-threatening medical complications of haematological malignancy.
        Br Med J (Clin Res Ed). 1988; 296: 1025-1029
        • Schuster D.P.
        • Marion J.M.
        Precedents for meaningful recovery during treatment in a medical intensive care unit. Outcome in patients with hematologic malignancy.
        Am J Med. 1983; 75: 402-408
        • Estopa R.
        • Torres Marti A.
        • Kastanos N.
        • et al.
        Acute respiratory failure in severe hematologic disorders.
        Crit Care Med. 1984; 12: 26-28
        • Groeger J.S.
        • White Jr., P.
        • Nierman D.M.
        • et al.
        Outcome for cancer patients requiring mechanical ventilation.
        J Clin Oncol. 1999; 17: 991-997
        • Chaoui D.
        • Legrand O.
        • Roche N.
        • et al.
        Incidence and prognostic value of respiratory events in acute leukemia.
        Leukemia. 2004; 18: 670-675
        • Hilbert G.
        • Gruson D.
        • Vargas F.
        • et al.
        Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure.
        N Engl J Med. 2001; 344: 481-487
        • Azoulay E.
        • Alberti C.
        • Bornstain C.
        • et al.
        Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support.
        Crit Care Med. 2001; 29: 519-525
        • Rubenfeld G.D.
        • Crawford S.W.
        Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines.
        Ann Intern Med. 1996; 125: 625-633
        • Huaringa A.J.
        • Leyva F.J.
        • Giralt S.A.
        • et al.
        Outcome of bone marrow transplantation patients requiring mechanical ventilation.
        Crit Care Med. 2000; 28: 1014-1017
        • Afessa B.
        • Tefferi A.
        • Hoagland H.C.
        • et al.
        Outcome of recipients of bone marrow transplants who require intensive-care unit support.
        Mayo Clin Proc. 1992; 67: 117-122
        • Faber-Langendoen K.
        • Caplan A.L.
        • McGlave P.B.
        Survival of adult bone marrow transplant patients receiving mechanical ventilation: a case for restricted use.
        Bone Marrow Transplant. 1993; 12: 501-507
        • Paz H.L.
        • Crilley P.
        • Weinar M.
        • et al.
        Outcome of patients requiring medical ICU admission following bone marrow transplantation.
        Chest. 1993; 104: 527-531
        • Denardo S.J.
        • Oye R.K.
        • Bellamy P.E.
        Efficacy of intensive care for bone marrow transplant patients with respiratory failure.
        Crit Care Med. 1989; 17: 4-6
        • Scott P.H.
        • Morgan T.J.
        • Durrant S.
        • et al.
        Survival following mechanical ventilation of recipients of bone marrow transplants and peripheral blood stem cell transplants.
        Anaesth Intensive Care. 2002; 30: 289-294
        • Price K.J.
        • Thall P.F.
        • Kish S.K.
        • et al.
        Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit.
        Am J Respir Crit Care Med. 1998; 158: 876-884
        • Jackson S.R.
        • Tweeddale M.G.
        • Barnett M.J.
        • et al.
        Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors.
        Bone Marrow Transplant. 1998; 21: 697-704
        • Bach P.B.
        • Schrag D.
        • Nierman D.M.
        • et al.
        Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation.
        Blood. 2001; 98: 3234-3240
        • Peigne V.
        • Rusinová K.
        • Karlin L.
        • et al.
        Continued survival gains in recent years among critically ill myeloma patients.
        Intensive Care Med. 2009; 35: 512-518
        • Pastores S.M.
        Acute respiratory failure in critically ill patients with cancer. Diagnosis and management.
        Crit Care Clin. 2001; 17 ([review]): 623-646
        • Azoulay E.
        • Schlemmer B.
        Diagnostic strategy in cancer patients with acute respiratory failure.
        Intensive Care Med. 2006; 32 ([review]): 808-822
        • Ginsberg R.J.
        • Hill L.D.
        • Eagan R.T.
        • et al.
        Modern thirty-day operative mortality for surgical resections in lung cancer.
        J Thorac Cardiovasc Surg. 1983; 86: 654-658
        • Licker M.
        • Fauconnet P.
        • Villiger Y.
        • et al.
        Acute lung injury and outcomes after thoracic surgery.
        Curr Opin Anaesthesiol. 2009; 22 ([review]): 61-67
        • Murthy S.C.
        • Rozas M.S.
        • Adelstein D.J.
        • et al.
        Induction chemoradiotherapy increases pleural and pericardial complications after esophagectomy for cancer.
        J Thorac Oncol. 2009; 4: 395-403
        • Stover D.E.
        • Kaner R.J.
        Pulmonary complications in cancer patients.
        CA Cancer J Clin. 1996; 46 ([review]): 303-320
        • Collin B.A.
        • Ramphal R.
        Pneumonia in the compromised host including cancer patients and transplant patients.
        Infect Dis Clin North Am. 1998; 12: 781-805
        • Alberts W.M.
        Pulmonary complications of cancer treatment.
        Curr Opin Oncol. 1997; 9: 161
        • Vento S.
        • Cainelli F.
        • Temesgen Z.
        Lung infections after cancer chemotherapy.
        Lancet Oncol. 2008; 9 ([review]): 982-992
        • Safdar A.
        • Rolston K.V.
        Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer.
        Clin Infect Dis. 2007; 45 ([review]): 1602-1609
        • Paez J.I.
        • Costa S.F.
        Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review.
        J Hosp Infect. 2008; 70 ([review]): 101-108
        • Gruson D.
        • Hilbert G.
        • Valentino R.
        • et al.
        Utility of fiberoptic bronchoscopy in neutropenic patients admitted to the intensive care unit with pulmonary infiltrates.
        Crit Care Med. 2000; 28: 2224-2230
        • Boersma W.G.
        • Erjavec Z.
        • van der Werf T.S.
        • et al.
        Bronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL.
        Respir Med. 2007; 101: 317-325
        • Zihlif M.
        • Khanchandani G.
        • Ahmed H.P.
        • et al.
        Surgical lung biopsy in patients with hematological malignancy or hematopoietic stem cell transplantation and unexplained pulmonary infiltrates: improved outcome with specific diagnosis.
        Am J Hematol. 2005; 78: 94-99
        • White D.A.
        • Wong P.W.
        • Downey R.
        The utility of open lung biopsy in patients with hematologic malignancies.
        Am J Respir Crit Care Med. 2000; 161: 723-729
        • Thomas Jr., C.F.
        • Limper A.H.
        Pneumocystis pneumonia.
        N Engl J Med. 2004; 350: 2487-2498
        • Roblot F.
        • Imbert S.
        • Godet C.
        • et al.
        Risk factors analysis for Pneumocystis jiroveci pneumonia (PCP) in patients with haematological malignancies and pneumonia.
        Scand J Infect Dis. 2004; 36: 848-854
        • Rai K.R.
        • Freter C.E.
        • Mercier R.J.
        • et al.
        Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.
        J Clin Oncol. 2002; 20: 3891-3897
        • Bollee G.
        • Sarfati C.
        • Thiery G.
        • et al.
        Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients.
        Chest. 2007; 132: 1305-1310
        • Azoulay E.
        • Bergeron A.
        • Chevret S.
        • et al.
        Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates.
        Chest. 2009; 135: 655-661
        • Martino R.
        • Porras R.P.
        • Rabella N.
        • et al.
        Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies.
        Biol Blood Marrow Transplant. 2005; 11: 781-796
        • Nichols W.G.
        • Corey L.
        • Gooley T.
        • et al.
        Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome.
        Blood. 2001; 98: 573-578
        • Chemaly R.F.
        • Ghosh S.
        • Bodey G.P.
        • et al.
        Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center.
        Medicine (Baltimore). 2006; 85: 278-287
        • Peck A.J.
        • Englund J.A.
        • Kuypers J.
        • et al.
        Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection.
        Blood. 2007; 110: 1681-1688
        • Shorr A.F.
        • Susla G.M.
        • O'Grady N.P.
        Pulmonary infiltrates in the non-HIV-infected immunocompromised patient: etiologies, diagnostic strategies, and outcomes.
        Chest. 2004; 125 ([review]): 260-271
        • van Elden L.J.
        • van Kraaij M.G.
        • Nijhuis M.
        • et al.
        Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with hematological cancer and pneumonia.
        Clin Infect Dis. 2002; 34: 177-183
        • Bernard G.R.
        • Artigas A.
        • Brigham K.L.
        • et al.
        The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.
        Am J Respir Crit Care Med. 1994; 149: 818-824
        • Luhr O.R.
        • Antonsen K.
        • Karlsson M.
        • et al.
        Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. The ARF Study Group.
        Am J Respir Crit Care Med. 1999; 159: 1849-1861
        • Wind J.
        • Versteegt J.
        • Twisk J.
        • et al.
        Epidemiology of acute lung injury and acute respiratory distress syndrome in The Netherlands: a survey.
        Respir Med. 2007; 101: 2091-2098
        • Rubenfeld G.D.
        • Caldwell E.
        • Peabody E.
        • et al.
        Incidence and outcomes of acute lung injury.
        N Engl J Med. 2005; 353: 1685-1693
        • Rubenfeld G.D.
        • Herridge M.S.
        Epidemiology and outcomes of acute lung injury.
        Chest. 2007; 131 ([review]): 554-562
        • Jeon K.
        • Yoon J.W.
        • Suh G.Y.
        • et al.
        Risk factors for post-pneumonectomy acute lung injury/acute respiratory distress syndrome in primary lung cancer patients.
        Anaesth Intensive Care. 2009; 37: 14-19
        • Kutlu C.A.
        • Williams E.A.
        • Evans T.W.
        • et al.
        Acute lung injury and acute respiratory distress syndrome after pulmonary resection.
        Ann Thorac Surg. 2000; 69: 376-380
        • Dulu A.
        • Pastores S.M.
        • Park B.
        • et al.
        Prevalence and mortality of acute lung injury and ARDS after lung resection.
        Chest. 2006; 130: 73-78
        • Ware L.B.
        • Matthay M.A.
        The acute respiratory distress syndrome.
        N Engl J Med. 2000; 342: 1334-1349
        • Laufe M.D.
        • Simon R.H.
        • Flint A.
        • et al.
        Adult respiratory distress syndrome in neutropenic patients.
        Am J Med. 1986; 80: 1022-1026
        • Kress J.P.
        • Christenson J.
        • Pohlman A.S.
        • et al.
        Outcomes of critically ill cancer patients in a university hospital setting.
        Am J Respir Crit Care Med. 1999; 160: 1957-1961
        • Nelson S.
        • Belknap S.M.
        • Carlson R.W.
        • et al.
        A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study Group.
        J Infect Dis. 1998; 178: 1075-1080
        • Wheeler A.P.
        • Bernard G.R.
        • Thompson B.T.
        • et al.
        Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury.
        N Engl J Med. 2006; 354: 2213-2224
        • Wiedemann H.P.
        • Wheeler A.P.
        • Bernard G.R.
        • et al.
        Comparison of two fluid-management strategies in acute lung injury.
        N Engl J Med. 2006; 354: 2564-2575
        • Mercat A.
        • Richard J.C.
        • Vielle B.
        • et al.
        Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial.
        JAMA. 2008; 299: 646-655
        • Stewart R.M.
        • Park P.K.
        • Hunt J.P.
        • et al.
        Less is more: improved outcomes in surgical patients with conservative fluid administration and central venous catheter monitoring.
        J Am Coll Surg. 2009; 208: 725-735
        • Brower R.G.
        • Lanken P.N.
        • MacIntyre N.
        • et al.
        Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome.
        N Engl J Med. 2004; 351: 327-336
      1. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network.
        N Engl J Med. 2000; 342: 1301-1308
        • Talmor D.
        • Sarge T.
        • Malhotra A.
        • et al.
        Mechanical ventilation guided by esophageal pressure in acute lung injury.
        N Engl J Med. 2008; 359: 2095-2104
        • Meduri G.U.
        • Headley A.S.
        • Golden E.
        • et al.
        Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial.
        JAMA. 1998; 280: 159-165
        • Steinberg K.P.
        • Hudson L.D.
        • Goodman R.B.
        • et al.
        Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.
        N Engl J Med. 2006; 354: 1671-1684
        • Hough C.L.
        • Steinberg K.P.
        • Taylor Thompson B.
        • et al.
        Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS.
        Intensive Care Med. 2009; 35: 63-68
        • Meduri G.U.
        • Marik P.E.
        • Chrousos G.P.
        • et al.
        Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature.
        Intensive Care Med. 2008; 34: 61-69
        • Zambon M.
        • Vincent J.L.
        Mortality rates for patients with acute lung injury/ARDS have decreased over time.
        Chest. 2008; 133: 1120-1127
        • Erickson S.E.
        • Martin G.S.
        • Davis J.L.
        • et al.
        Recent trends in acute lung injury mortality: 1996–2005.
        Crit Care Med. 2009; 37: 1574-1579
        • Davidson T.A.
        • Caldwell E.S.
        • Curtis J.R.
        • et al.
        Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients.
        JAMA. 1999; 281: 354-360
        • Dowdy D.W.
        • Bienvenu O.J.
        • Dinglas V.D.
        • et al.
        Are intensive care factors associated with depressive symptoms 6 months after acute lung injury?.
        Crit Care Med. 2009; 37: 1702-1707
        • Hopkins R.O.
        • Weaver L.K.
        • Collingridge D.
        • et al.
        Two-year cognitive, emotional, and quality-of-life outcomes in acute respiratory distress syndrome.
        Am J Respir Crit Care Med. 2005; 171: 340-347
        • Herridge M.S.
        • Cheung A.M.
        • Tansey C.M.
        • et al.
        Canadian Critical Care Trials Group. One-year outcomes in survivors of the acute respiratory distress syndrome.
        N Engl J Med. 2003; 348: 683-693
        • Kress J.P.
        • Pohlman A.S.
        • O'Connor M.F.
        • et al.
        Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation.
        N Engl J Med. 2000; 342: 1471-1477
        • Girard T.D.
        • Kress J.P.
        • Fuchs B.D.
        • et al.
        Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial.
        Lancet. 2008; 371: 126-134
        • Schweickert W.D.
        • Pohlman M.C.
        • Pohlman A.S.
        • et al.
        Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial.
        Lancet. 2009; 373: 1874-1882
        • Vahid B.
        • Marik P.E.
        Pulmonary complications of novel antineoplastic agents for solid tumors.
        Chest. 2008; 133 ([review]): 528-538
        • Ohnishi H.
        • Yokoyama A.
        • Yasuhara Y.
        • et al.
        Circulating KL-6 levels in patients with drug induced pneumonitis.
        Thorax. 2003; 58: 872-875
        • Camus P.
        • Kudoh S.
        • Ebina M.
        Interstitial lung disease associated with drug therapy.
        Br J Cancer. 2004; 91 ([review]): S18-S23
        • Sallah S.
        • Wan J.Y.
        • Nguyen N.P.
        Venous thrombosis in patients with solid tumors: determination of frequency and characteristics.
        Thromb Haemost. 2002; 87: 575-579
        • Heit J.A.
        • Silverstein M.D.
        • Mohr D.N.
        • et al.
        Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.
        Arch Intern Med. 2000; 160: 809-815
        • Lee A.Y.
        • Levine M.N.
        Venous thromboembolism and cancer: risks and outcomes.
        Circulation. 2003; 107: I17-I21
        • DeSancho M.T.
        • Rand J.H.
        Bleeding and thrombotic complications in critically ill patients with cancer.
        Crit Care Clin. 2001; 17 ([review]): 599-622
        • Stein P.D.
        • Woodard P.K.
        • Weg J.G.
        • et al.
        PIOPED II investigators. Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II investigators.
        Am J Med. 2006; 119: 1048-1055
        • Anderson D.R.
        • Kahn S.R.
        • Rodger M.A.
        • et al.
        Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial.
        JAMA. 2007; 298: 2743-2753
        • Stein P.D.
        • Fowler S.E.
        • Goodman L.R.
        • et al.
        PIOPED II Investigators. Multidetector computed tomography for acute pulmonary embolism.
        N Engl J Med. 2006; 354: 2317-2327
        • Lee A.Y.
        • Julian J.A.
        • Levine M.N.
        • et al.
        Clinical utility of a rapid whole-blood D-dimer assay in patients with cancer who present with suspected acute deep venous thrombosis.
        Ann Intern Med. 1999; 131: 417-423
        • van Belle A.
        • Büller H.R.
        • Huisman M.V.
        • et al.
        Christopher Study Investigators. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography.
        JAMA. 2006; 295: 172-179
        • Petralia G.A.
        • Kakkar A.K.
        Treatment of venous thromboembolism in cancer patients.
        Semin Thromb Hemost. 2007; 33: 707-711
        • Pastores S.M.
        Management of venous thromboembolism in the intensive care unit.
        J Crit Care. 2009; 24: 185-191
        • Kearon C.
        • Kahn S.R.
        • Agnelli G.
        • et al.
        American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition).
        Chest. 2008; 133 (Erratum in: Chest 2008;134(4):892): 454S-545S
        • Warkentin T.E.
        • Greinacher A.
        • Koster A.
        • et al.
        American College of Chest Physicians. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition).
        Chest. 2008; 133: 340S-380S
        • Simonneau G.
        • Sors H.
        • Charbonnier B.
        • et al.
        A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Héparine Standard: Évaluations dans l'Embolie Pulmonaire.
        N Engl J Med. 1997; 337: 663-669
      2. The Columbus Investigators. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism.
        N Engl J Med. 1997; 337: 657-662
        • Carlbom D.J.
        • Davidson B.L.
        Pulmonary embolism in the critically ill.
        Chest. 2007; 132: 313-324
        • Konstantinides S.
        Clinical practice. Acute pulmonary embolism.
        N Engl J Med. 2008; 359: 2804-2813
        • Schunn C.
        • Schunn G.B.
        • Hobbs G.
        • et al.
        Inferior vena cava filter placement in late-stage cancer.
        Vasc Endovascular Surg. 2006; 40: 287-294
        • Decousus H.
        • Leizorovicz A.
        • Parent F.
        • et al.
        A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.
        N Engl J Med. 1998; 338: 409-415
        • Streiff M.B.
        Vena caval filters: a review for intensive care specialists.
        J Intensive Care Med. 2003; 18: 59-79
        • Afessa B.
        • Tefferi A.
        • Litzow M.R.
        • et al.
        Diffuse alveolar hemorrhage in hematopoietic stem cell recipients.
        Am J Respir Crit Care Med. 2002; 166: 641-645
        • Lewis I.D.
        • DeFor T.
        • Weisdorf D.J.
        Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy.
        Bone Marrow Transplant. 2000; 26: 539-543
        • Metcalf J.P.
        • Rennard S.I.
        • Reed E.C.
        • et al.
        Corticosteroids as adjunctive therapy for diffuse alveolar hemorrhage associated with bone marrow transplantation: University of Nebraska Medical Center Bone Marrow Transplant Group.
        Am J Med. 1994; 96: 327-334
        • Pastores S.M.
        • Papadopoulos E.
        • Voigt L.
        • et al.
        Diffuse alveolar hemorrhage after allogeneic hematopoietic stem-cell transplantation: treatment with recombinant factor VIIa.
        Chest. 2003; 124: 2400-2403
        • Heslet L.
        • Nielsen J.D.
        • Levi M.
        • et al.
        Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage.
        Crit Care. 2006; 10: R177
        • Kotloff R.M.
        • Ahya V.N.
        • Crawford S.W.
        Pulmonary complications of solid organ and hematopoietic stem cell transplantation.
        Am J Respir Crit Care Med. 2004; 170: 22-48
        • Jawa R.S.
        • Anillo S.
        • Kulaylat M.N.
        Transfusion-related acute lung injury.
        J Intensive Care Med. 2008; 23 ([review]): 109-121
        • Triulzi D.J.
        Transfusion-related acute lung injury: current concepts for the clinician.
        Anesth Analg. 2009; 108: 770-776
        • Gajic O.
        • Moore S.B.
        Transfusion-related acute lung injury.
        Mayo Clin Proc. 2005; 80 ([review]): 766-770
        • Marks L.B.
        • Yu X.
        • Vujaskovic Z.
        • et al.
        Radiation-induced lung injury.
        Semin Radiat Oncol. 2003; 13 ([review]): 333-345
        • Provatopoulou X.
        • Athanasiou E.
        • Gounaris A.
        Predictive markers of radiation pneumonitis.
        Anticancer Res. 2008; 28: 2421-2432
        • Ghafoori P.
        • Marks L.B.
        • Vujaskovic Z.
        • et al.
        Radiation-induced lung injury. Assessment, management, and prevention.
        Oncology (Williston Park). 2008; 22 ([discussion: 52–3]): 37-47
        • Titulaer M.J.
        • Wirtz P.W.
        • Willems L.N.
        • et al.
        Screening for small-cell lung cancer: a follow-up study of patients with Lambert-Eaton myasthenic syndrome.
        J Clin Oncol. 2008; 26: 4276
        • Lang B.
        • Pinto A.
        • Giovannini F.
        • et al.
        Pathogenic autoantibodies in the Lambert-Eaton myasthenic syndrome.
        Ann N Y Acad Sci. 2003; 998: 187
        • Maddison P.
        • Newsom-Davis J.
        Treatment for Lambert-Eaton myasthenic syndrome.
        Cochrane Database Syst Rev. 2005; ([review]) (CD003279)
        • Mehta S.
        Neuromuscular disease causing acute respiratory failure.
        Respir Care. 2006; 51: 1016-1021
        • Soares M.
        • Salluh J.I.
        • Azoulay E.
        Noninvasive ventilation in patients with malignancies and hypoxemic acute respiratory failure: a still pending question.
        J Crit Care. 2009; ([Epub ahead of print])
        • Marik P.E.
        Noninvasive positive-pressure ventilation in patients with malignancy.
        Am J Hosp Palliat Care. 2007; 24 ([review]): 417-421
        • Girard T.D.
        • Bernard G.R.
        Mechanical ventilation in ARDS: a state-of-the-art review.
        Chest. 2007; 131 ([review]): 921-929
        • Soares M.
        • Salluh J.I.
        Validation of the SAPS 3 admission prognostic model in patients with cancer in need of intensive care.
        Intensive Care Med. 2006; 32: 1839-1844
        • Curtis J.R.
        • White D.B.
        Practical guidance for evidence-based ICU family conferences.
        Chest. 2008; 134 ([review]): 835-843
        • Lautrette A.
        • Darmon M.
        • Megarbane B.
        • et al.
        A communication strategy and brochure for relatives of patients dying in the ICU.
        N Engl J Med. 2007; 356 ([Erratum in: N Engl J Med 2007 Jul 12;357(2):203]): 469-478
        • Lilly C.M.
        • De Meo D.L.
        • Sonna L.A.
        • et al.
        An intensive communication intervention for the critically ill.
        Am J Med. 2000; 109: 469-475
        • Gries C.J.
        • Curtis J.R.
        • Wall R.J.
        • et al.
        Family member satisfaction with end-of-life decision making in the ICU.
        Chest. 2008; 133: 704-712
        • Wright A.A.
        • Zhang B.
        • Ray A.
        • et al.
        Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment.
        JAMA. 2008; 300: 1665-1673
        • Schneiderman L.J.
        • Gilmer T.
        • Teetzel H.D.
        • et al.
        Effect of ethics consultations on nonbeneficial life-sustaining treatments in the intensive care setting: a randomized controlled trial.
        JAMA. 2003; 290: 1166-1172
        • Campbell M.L.
        • Guzman J.A.
        Impact of a proactive approach to improve end-of-life care in a medical ICU.
        Chest. 2003; 123: 266-271